Compare Dr. Reddys with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs FULFORD INDIA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB FULFORD INDIA DR. REDDYS LAB/
FULFORD INDIA
 
P/E (TTM) x 21.1 398.8 5.3% View Chart
P/BV x 3.2 6.2 50.7% View Chart
Dividend Yield % 0.7 0.1 885.0%  

Financials

 DR. REDDYS LAB   FULFORD INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
FULFORD INDIA
Mar-14
DR. REDDYS LAB/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs2,875942 305.2%   
Low Rs1,888450 419.6%   
Sales per share (Unadj.) Rs930.2691.4 134.5%  
Earnings per share (Unadj.) Rs117.411.5 1,024.5%  
Cash flow per share (Unadj.) Rs185.815.4 1,209.4%  
Dividends per share (Unadj.) Rs20.002.00 1,000.0%  
Dividend yield (eoy) %0.80.3 292.3%  
Book value per share (Unadj.) Rs844.4380.0 222.2%  
Shares outstanding (eoy) m166.073.90 4,258.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.61.0 254.3%   
Avg P/E ratio x20.360.7 33.4%  
P/CF ratio (eoy) x12.845.3 28.3%  
Price / Book Value ratio x2.81.8 154.0%  
Dividend payout %17.017.4 97.6%   
Avg Mkt Cap Rs m395,4962,714 14,570.3%   
No. of employees `00022.00.4 4,947.3%   
Total wages/salary Rs m33,562505 6,645.9%   
Avg. sales/employee Rs Th7,032.86,073.0 115.8%   
Avg. wages/employee Rs Th1,527.91,137.4 134.3%   
Avg. net profit/employee Rs Th887.7100.7 881.8%   
INCOME DATA
Net Sales Rs m154,4822,696 5,729.2%  
Other income Rs m3,375125 2,691.4%   
Total revenues Rs m157,8572,822 5,594.2%   
Gross profit Rs m31,782-46 -68,495.7%  
Depreciation Rs m11,34815 74,657.9%   
Interest Rs m88910 9,357.9%   
Profit before tax Rs m22,92054 42,209.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,85810 40,187.5%   
Profit after tax Rs m19,50045 43,624.2%  
Gross profit margin %20.6-1.7 -1,195.6%  
Effective tax rate %16.817.7 95.2%   
Net profit margin %12.61.7 761.4%  
BALANCE SHEET DATA
Current assets Rs m111,1011,738 6,391.4%   
Current liabilities Rs m58,973545 10,826.7%   
Net working cap to sales %33.744.3 76.2%  
Current ratio x1.93.2 59.0%  
Inventory Days Days7948 163.7%  
Debtors Days Days944 2,188.3%  
Net fixed assets Rs m101,24512 850,798.3%   
Share capital Rs m83039 2,128.2%   
"Free" reserves Rs m139,4061,443 9,660.8%   
Net worth Rs m140,2361,482 9,462.6%   
Long term debt Rs m22,0000-   
Total assets Rs m224,6562,077 10,817.9%  
Interest coverage x26.86.7 398.8%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.71.3 53.0%   
Return on assets %9.12.6 347.7%  
Return on equity %13.93.0 461.0%  
Return on capital %14.94.3 347.2%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m88,67317 515,540.7%   
Fx outflow Rs m19,104673 2,838.0%   
Net fx Rs m69,569-656 -10,605.7%   
CASH FLOW
From Operations Rs m28,70490 31,893.3%  
From Investments Rs m-7,727105 -7,387.2%  
From Financial Activity Rs m-21,326-14 151,248.2%  
Net Cashflow Rs m-314181 -174.0%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 3.8 142.1%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 21.2 72.2%  
Shareholders   75,885 4,783 1,586.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare DR. REDDYS LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Oct 14, 2019 01:35 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS